tiprankstipranks
Lattice Biologics Ltd (TSE:LBL.H)
TSXV:LBL.H
Canadian Market
Holding TSE:LBL.H?
Track your performance easily

Lattice Biologics (LBL.H) Income Statement

3 Followers

Lattice Biologics Income Statement

Last quarter (Q2 2021), Lattice Biologics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q2, Lattice Biologics's net income was $―. See Lattice Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 20Sep 19Sep 18Sep 17Sep 16
Total Revenue
$ 1.56M$ 2.46M$ 2.19M$ 1.16M$ 2.74M$ 3.78M
Cost of Revenue
$ 1.11M$ 1.44M$ 1.25M$ 613.89K$ 2.17M$ 2.96M
Gross Profit
$ 444.55K$ 1.02M$ 942.76K$ 541.15K$ 571.11K$ 816.69K
Operating Expense
$ 1.06M$ 1.36M$ 1.53M$ 2.03M$ 3.39M$ 7.29M
Operating Income
----$ -846.11K$ -451.92K
Net Non Operating Interest Income Expense
$ -571.62K$ -808.77K$ -544.27K$ -467.03K$ -1.17M$ -1.04M
Other Income Expense
$ -354.75K$ 337.99K$ -34.19K$ 161.52K$ -2.37M$ -120.60K
Pretax Income
$ -832.60K$ -1.48M$ -1.10M$ -2.11M$ -2.46M$ -7.85M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
------
Basic EPS
$ -0.01$ -0.01$ -0.01$ -0.01$ -0.02$ -0.16
Diluted EPS
------
Basic Average Shares
$ 487.23M$ 102.58M$ 93.46M$ 93.46M$ 78.00M$ 48.15M
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
$ -832.60K$ -1.48M$ -1.10M$ -2.11M$ -2.46M$ -7.85M
Normalized Income
$ -722.00K$ -1.09M$ -805.30K$ -1.55M$ -961.91K$ -5.32M
Interest Expense
------
EBIT
$ -260.98K$ -673.87K$ -551.38K$ -1.65M$ -1.99M$ -6.81M
EBITDA
$ -29.55K$ -292.96K$ -347.28K$ -1.44M$ -1.77M$ -6.33M
Currency in USD

Lattice Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis